R&D
Andelyn to Manufacture a Gene Therapy for Tay-Sachs and Sandhoff Diseases
The manufacturer will produce an AAV9 gene therapy for GM2 gangliosidosis — a group of fatal inherited disorders — developed with Queen’s University ahead of planned clinical trials.